In a more recent study, Toy et al. analyzed 929 breast cancer samples and observed a frequency of ESR1 mutations of 3.5% in primary tumors and 13.6% in metastatic tumors; ESR1 mutations were found in ER+ tumors, but not in TNBC [173]. This evidence concerns the gene ESR1 and metastatic neoplasm.